drugset / Trial / NCT00361218
Biological Markers of Response to Treatment in Major Depressive Disorder
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if two tests are useful in predicting whether someone with depression will get better when he or she is treated with an FDA approved antidepressant medication (either citalopram or escitalopram).
Timeline
- Start
- 2005-10
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citalopram | Small molecule | — | Oral |
| Subject | Escitalopram | Small molecule | — | Oral |